Troutman Pepper advised Hikma Pharmaceuticals PLC on the deal. Hikma Pharmaceuticals PLC, a multinational pharmaceutical company, has acquired Custopharm Inc. from Water Street Healthcare Partners, following...
Hikma Pharmaceuticals’ $375 Million Acquisition of Custopharm
Apnimed’s Series C Financing
Troutman Pepper advised Apnimed on the deal. Apnimed, a clinical-stage pharmaceutical company focused on developing oral pharmacologic treatments to address obstructive sleep apnea (OSA) and related...
Collegium Pharmaceutical’s Acquisition of BioDelivery Sciences International
Goodwin Procter advised BioDelivery Sciences International on the deal while Troutman Pepper advised Collegium Pharmaceutical. BioDelivery Sciences International (NASDAQ: BDSI) announced its definitive merger agreement to be...
SK Group’s $350 Million Investment in The Center for Breakthrough Medicines
Simpson Thacher represented SK Group on the deal while Troutman Pepper Hamilton Sanders advised Center for Breakthrough Medicines. SK Inc. announced its $350 million investment in The...
In Re: National Prescription Opiate Litigation
Robbins Geller Rudman & Dowd, Seeger Weiss Newark, Plevin & Gallucci, Bertram & Graf, Irpino, Avin & Hawkins, Powell & Majestro, Dugan Law Firm, Cooper Law...
PharmaCyte Biotech’s $15 Million Follow-On Public Offering
Troutman Pepper Hamilton Sanders advised PharmaCyte Biotech, Inc. on the deal. PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer...
Eurofins’ Acquisition of DNA Diagnostics Center
Ropes & Gray, working alongside Troutman Pepper, acted as legal advisors to DNA Diagnostics Center and investment fund GHO Capital. DNA Diagnostics Center announced the definitive agreement...
Inhibikase Therapeutics’ $45 Million Follow-On Public Offering
Troutman Pepper Hamilton Sanders LLP advised Inhibikase Therapeutics, Inc. on the deal. Inhibikase Therapeutics, Inc. (Nasdaq: IKT), a clinical-stage pharmaceutical company developing therapeutics to modify the...